Imagen de Portada

Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Chia‐Yu Chiu, Maryam Mahmood, Raymund R. Razonable, Elena Beam
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical Transplantation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
por: Vaisak O. Nair, et al.
Publicado: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
por: Lemuel R. Non, et al.
Publicado: (2024)

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
por: Abdallah Mughrabi, et al.
Publicado: (2026)

Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients
por: Chia‐Yu Chiu, et al.
Publicado: (2024)

The impact of active cytomegalovirus infection on donor‐derived cell‐free DNA testing in heart transplant recipients
por: Amit H. Alam, et al.
Publicado: (2024)

Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis
por: David Moynan, et al.
Publicado: (2024)

Epstein–Barr Virus‐Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study
por: Laurène Tardieu, et al.
Publicado: (2024)

The Impact of Epstein–Barr Virus Serostatus Mismatch in Adult Kidney Transplant Recipients: An Analysis of the 2012–2022 OPTN Database
por: Namrata Parikh, et al.
Publicado: (2025)

Induction Regimens and Kidney Re‐Transplant Outcomes after BK Nephropathy–Related Graft Loss: A U.S. Cohort Study
por: Rasha El‐Rifai, et al.
Publicado: (2026)

Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
por: Maria Alejandra Mendoza, et al.
Publicado: (2024)

Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients
por: Grégoire Saltiel, et al.
Publicado: (2024)

Recipient donor sex combinations in solid organ transplantation and impact on clinical outcome: A scoping review
por: Christian Tibor Josef Magyar, et al.
Publicado: (2024)

Single center utilization and post‐transplant outcomes of thoracoabdominal normothermic regional perfusion deceased cardiac donor organs
por: Jennifer D. Motter, et al.
Publicado: (2024)

Effect of the opioid crisis on the liver transplantation donor pool: A national analysis
por: Yutaka Endo, et al.
Publicado: (2024)

Improving value delivery in living donor kidney transplant through process improvement
por: Jorge Sanchez Garcia, et al.
Publicado: (2024)

Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
por: Bernard S. Kadosh, et al.
Publicado: (2024)

Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
por: Lien‐Chung Wei, et al.
Publicado: (2025)

Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort
por: Manuela Almeida, et al.
Publicado: (2024)

“You don't know what you don't know”: A qualitative study of informational needs of patients, family members, and living donors to inform transplant system metrics
por: Allyson Hart, et al.
Publicado: (2024)

Comparison of postoperative ascites replacement strategies on time to first flatus after living donor liver transplantation: Albumin vs. lactated Ringer's solution
por: Seung‐Young Oh, et al.
Publicado: (2024)

Treatment Options for Bronchiolitis Obliterans Secondary to Hematopoietic Cell Transplantation in Children: A Systematic Review
por: Amirali Kalantari, et al.
Publicado: (2025)

Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients
por: Song Peng Ang, et al.
Publicado: (2025)

Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
por: Jessica Hedvat, et al.
Publicado: (2024)

Safety and utility of panniculectomy in renal transplant candidates and end stage renal disease patients
por: Matteo Laspro, et al.
Publicado: (2024)

Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients
por: Kevin D. He, et al.
Publicado: (2024)

Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
por: Emily Eribes, et al.
Publicado: (2024)

A pragmatic tool to screen for pre‐transplant cognitive impairment among potential candidates for liver transplant
por: Mayan S. Teles, et al.
Publicado: (2024)

Reduced Functional Status among Kidney Transplant Recipients over Time and Associated Risks Post‐Transplant
por: Sage L. Dixon, et al.
Publicado: (2025)

Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
por: Jennifer L. Alejo, et al.
Publicado: (2024)

Cardiovascular outcomes in solid organ transplant recipients undergoing cardiac surgery: A matched pair analysis
por: Kitae Kim, et al.
Publicado: (2024)

Stepwise development and expansion of an abdominal normothermic regional perfusion program for donation after circulatory determination of death organ procurement
por: Anji Wall, et al.
Publicado: (2024)

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records
por: Krista L. Lentine, et al.
Publicado: (2024)

Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Marzieh Izadifard, et al.
Publicado: (2024)

Implementation of a Comprehensive Protocol for Enhanced Recovery After Surgery (ERAS) in Kidney Transplant Recipients Improves Patient and Graft Outcomes
por: Mohamed Eltemamy, et al.
Publicado: (2024)

Posttransplant HBV Vaccine Compliance, Seroprotection, and Kinetics of Hepatitis B Surface Antibody in Thoracic Organ Transplant Recipients
por: Chia‐Yu Chiu, et al.
Publicado: (2025)

Continuous Renal Replacement Therapy During Liver Transplant: The Anesthesiologist‐Nephrologist Collaboration at a Tertiary University Hospital in Italy
por: Cristiana Laici, et al.
Publicado: (2026)

Association Between Split Function of the Retained Kidney and Early Changes in Kidney Function After Living Kidney Donation
por: Syed Ali Husain, et al.
Publicado: (2024)

Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients
por: Catherine Burton, et al.
Publicado: (2025)

Long‐Term Outcomes of Hematopoietic Stem Cell Transplantation in Mucopolysaccharidoses Patients Without Radiation
por: Mohammad Jahanpanah, et al.
Publicado: (2025)

Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy
por: Hildegard T. Greinix, et al.
Publicado: (2025)